국내 임상진료지침의 개발 현황
An Investigation of Current Status of the Clinical Practice Guidelines in Korea
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objective: Clinical practice guidelines (CPGs) are systematically developed statements aimed at helping optimal care of the patient in a given clinical circumstance. Because of the increasing evidence that active implementation of CPGs improve health outcomes, there is a growing awareness of the importance of guideline development and dissemination. The objective of this study was to investigate the status of CPG development and availability of the CPGs in Korea. Method: We searched in the Web sites of 180 organizations to identify CPGs which were developed and/or published in Korea until 1 July 2014. The data of titles, published year, publisher, distributer, and accessibility at the internet web of all CPGs were collected and analyzed. Results: A total of 172 CPGs were developed and 80% had been released since 2009. Most (51.2%) were developed for management of 4 diseases: 28 for digestive system disease; 27 for infectious disease; 18 for endocrine and metabolic diseases; and 15 for neoplasms. Of the 172 CPGs, 150 CPGs were publicly available. Among the 150 CPGs, 78.7% (118/150) were developed by only one organization. Conclusion: To ensure the production of high-quality CPGs, it is necessary to collaborate with other relevant professional societies in guideline development process. In addition, stronger efforts on wider dissemination of CPGs must be employed at the country levels to promote implementation of CPGs in clinical settings.
Abstract
Objective: Clinical practice guidelines (CPGs) are systematically developed statements aimed at helping optimal care of the patient in a given clinical circumstance. Because of the increasing evidence that active implementation of CPGs improve health outcomes, there is a growing awareness of the importance of guideline development and dissemination. The objective of this study was to investigate the status of CPG development and availability of the CPGs in Korea. Method: We searched in the Web sites of 180 organizations to identify CPGs which were developed and/or published in Korea until 1 July 2014. The data of titles, published year, publisher, distributer, and accessibility at the internet web of all CPGs were collected and analyzed. Results: A total of 172 CPGs were developed and 80% had been released since 2009. Most (51.2%) were developed for management of 4 diseases: 28 for digestive system disease; 27 for infectious disease; 18 for endocrine and metabolic diseases; and 15 for neoplasms. Of the 172 CPGs, 150 CPGs were publicly available. Among the 150 CPGs, 78.7% (118/150) were developed by only one organization. Conclusion: To ensure the production of high-quality CPGs, it is necessary to collaborate with other relevant professional societies in guideline development process. In addition, stronger efforts on wider dissemination of CPGs must be employed at the country levels to promote implementation of CPGs in clinical settings.
참고문헌 (24)
- Field MJ., "Clinical practice guidelines : directions for a new program" (1990), National Academy Press
- Woolf SH., "Clinical guidelines : potential benefits, limitations, and harms of clinical guidelines", BMJ, 318(7182), pp.527~530 (1999)
- Delamothe T, "Wanted : guidelines that doctors will follow", BMJ, 307(6898), pp.218~ (1993)
- Grimshaw J., "Achieving health gain through clinical guidelines. I: Developing scientifically valid guidelines", Qual Health Care, 2(4), pp.243~248 (1993)
- Schünemann HJ., "WHO Advisory Committee on Health Research. Improving the use of research evidence in guideline development: 1. Guidelines for guidelines", Health Res Policy Syst, 4, pp.13~ (2006)
- Shekelle PG., "Clinical guidelines : developing guidelines", BMJ, 318(7183), pp.593~596 (1999)
- The AGREE Collaboration, "Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines : the AGREE project", Quality and Safety in Health Care, 12, pp.18~23 (2003)
- Brouwers MC., "AGREE II : advancing guideline development, reporting and evaluation in health care", J Clin Epidemiol, 63(12), pp.1308~1311 (2010)
- "National Guideline Clearinghouse"[URL]
- "Cancer Care Ontario"[URL]
- "NICE"[URL]
- "SIGN"[URL]
- "KoMGI"[URL]
- "KGC"[URL]
- ". ICD-10 Version:2010"[URL]
- Burgers JS., "AGREE Collaboration. Towards evidence-based clinical practice: an international survey of 18 clinical guideline programs", Int J Qual Health Care, 15, pp.31~45 (2003)
- 신인순, "국내 임상진료지침의 개발동향과 당면과제", 대한의사협회지, 55(4), pp.371~378 (2012), 대한의사협회[DOI]
- Eccles MP., "Developing clinical practice guidelines : target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest", Implement Sci, 7, pp.60~ (2012)
- Jacobs AK., "ACCF", AHA clinical practice guideline methodology summit report : a report of the American College of Cardiology Foundation, J Am Coll Cardiol, pp.2013, 61(2)[DOI]
- Vernooij RW., "Guidance for updating clinical practice guidelines : a systematic review of methodological handbooks", Implement Sci, 9, pp.3~ (2014)
- Scott IA., "Clinical practice guidelines : perspectives of clinicians in Queensland public hospitals", Intern Med J, 33(7), pp.273~279 (2003)
- Larisch A., "Attitudes and barriers to clinical practice guidelines in general and to the guideline on Parkinson's disease. A National Survey of German neurologists in private practice", J Neurol, 256(10), pp.1681~1688 (2009)
- Kryworuchko J., "Twelve years of clinical practice guideline development, dissemination and evaluation in Canada(1994 to 2005)", Implement Sci, 4, pp.49~ (2009)
- Graham ID., "The state of the science and art of practice guidelines development, dissemination and evaluation in Canada", J Eval Clin Pract, 9(2), pp.195~202 (2003)